146 related articles for article (PubMed ID: 24584698)
1. Rsf-1 overexpression in human prostate cancer, implication as a prognostic marker.
Li H; Zhang Y; Zhang Y; Bai X; Peng Y; He P
Tumour Biol; 2014 Jun; 35(6):5771-6. PubMed ID: 24584698
[TBL] [Abstract][Full Text] [Related]
2. Rsf-1 overexpression serves as a prognostic marker in human hepatocellular carcinoma.
Xie C; Fu L; Xie L; Liu N; Li Q
Tumour Biol; 2014 Aug; 35(8):7595-601. PubMed ID: 24798976
[TBL] [Abstract][Full Text] [Related]
3. Rsf-1 overexpression correlates with poor prognosis and cell proliferation in colon cancer.
Liu S; Dong Q; Wang E
Tumour Biol; 2012 Oct; 33(5):1485-91. PubMed ID: 22528946
[TBL] [Abstract][Full Text] [Related]
4. Rsf-1 is overexpressed in non-small cell lung cancers and regulates cyclinD1 expression and ERK activity.
Li Q; Dong Q; Wang E
Biochem Biophys Res Commun; 2012 Mar; 420(1):6-10. PubMed ID: 22387541
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Rsf-1 correlates with poor survival and promotes invasion in non-small cell lung cancer.
Zhang X; Fu L; Xue D; Zhang X; Hao F; Xie L; He J; Gai J; Liu Y; Xu H; Li Q; Wang E
Virchows Arch; 2017 May; 470(5):553-560. PubMed ID: 28289901
[TBL] [Abstract][Full Text] [Related]
6. Rsf-1/HBXAP overexpression is associated with disease-specific survival of patients with gallbladder carcinoma.
Chen TJ; Huang SC; Huang HY; Wei YC; Li CF
APMIS; 2011 Nov; 119(11):808-14. PubMed ID: 21995635
[TBL] [Abstract][Full Text] [Related]
7. Associations of Rsf-1 overexpression with poor therapeutic response and worse survival in patients with nasopharyngeal carcinoma.
Tai HC; Huang HY; Lee SW; Lin CY; Sheu MJ; Chang SL; Wu LC; Shiue YL; Wu WR; Lin CM; Li CF
J Clin Pathol; 2012 Mar; 65(3):248-53. PubMed ID: 22081787
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of hSNF2H in glioma promotes cell proliferation, invasion, and chemoresistance through its interaction with Rsf-1.
Zhao XC; An P; Wu XY; Zhang LM; Long B; Tian Y; Chi XY; Tong DY
Tumour Biol; 2016 Jun; 37(6):7203-12. PubMed ID: 26666816
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Rsf-1 correlates with pathological type, p53 status and survival in primary breast cancer.
Ren J; Chen QC; Jin F; Wu HZ; He M; Zhao L; Yu ZJ; Yao WF; Mi XY; Wang EH; Wei MJ
Int J Clin Exp Pathol; 2014; 7(9):5595-608. PubMed ID: 25337201
[TBL] [Abstract][Full Text] [Related]
10. SPAG9 is overexpressed in human prostate cancer and promotes cancer cell proliferation.
Li H; Peng Y; Niu H; Wu B; Zhang Y; Zhang Y; Bai X; He P
Tumour Biol; 2014 Jul; 35(7):6949-54. PubMed ID: 24740566
[TBL] [Abstract][Full Text] [Related]
11. Rsf-1 expression in rectal cancer: with special emphasis on the independent prognostic value after neoadjuvant chemoradiation.
Lin CY; Tian YF; Wu LC; Chen LT; Lin LC; Hsing CH; Lee SW; Sheu MJ; Lee HH; Wang YH; Shiue YL; Wu WR; Huang HY; Hsu HP; Li CF; Chen SH
J Clin Pathol; 2012 Aug; 65(8):687-92. PubMed ID: 22569540
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of a chromatin remodeling factor, RSF-1/HBXAP, correlates with aggressive oral squamous cell carcinoma.
Fang FM; Li CF; Huang HY; Lai MT; Chen CM; Chiu IW; Wang TL; Tsai FJ; Shih IeM; Sheu JJ
Am J Pathol; 2011 May; 178(5):2407-15. PubMed ID: 21514451
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
Zhang X; Wang Y; Ning Y
Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
[TBL] [Abstract][Full Text] [Related]
14. Expression of the chromatin remodeling factor Rsf-1 is down-regulated in breast carcinoma effusions.
Davidson B; Wang TL; Shih IeM; Berner A
Hum Pathol; 2008 Apr; 39(4):616-22. PubMed ID: 18289639
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of SMARCA5 correlates with cell proliferation and migration in breast cancer.
Jin Q; Mao X; Li B; Guan S; Yao F; Jin F
Tumour Biol; 2015 Mar; 36(3):1895-902. PubMed ID: 25377162
[TBL] [Abstract][Full Text] [Related]
16. Rsf-1/HBXAP overexpression is independent of gene amplification and is associated with poor outcome in patients with urinary bladder urothelial carcinoma.
Liang PI; Wu LC; Sheu JJ; Wu TF; Shen KH; Wang YH; Wu WR; Shiue YL; Huang HY; Hsu HP; Chen YH; Chen LT; Li CF; Liao AC
J Clin Pathol; 2012 Sep; 65(9):802-7. PubMed ID: 22685262
[TBL] [Abstract][Full Text] [Related]
17. Rsf-1 (HBXAP) expression is associated with advanced stage and lymph node metastasis in ovarian clear cell carcinoma.
Maeda D; Chen X; Guan B; Nakagawa S; Yano T; Taketani Y; Fukayama M; Wang TL; Shih IeM
Int J Gynecol Pathol; 2011 Jan; 30(1):30-5. PubMed ID: 21131837
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma.
Xu S; Yi XM; Tang CP; Ge JP; Zhang ZY; Zhou WQ
Oncol Rep; 2016 Jul; 36(1):10-22. PubMed ID: 27176634
[TBL] [Abstract][Full Text] [Related]
19. miR-129 predicts prognosis and inhibits cell growth in human prostate carcinoma.
Xu S; Yi XM; Zhang ZY; Ge JP; Zhou WQ
Mol Med Rep; 2016 Dec; 14(6):5025-5032. PubMed ID: 27779679
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Pleomorphic Adenoma Gene-Like 2 Is a Novel Poor Prognostic Marker of Prostate Cancer.
Guo J; Wang M; Wang Z; Liu X
PLoS One; 2016; 11(8):e0158667. PubMed ID: 27537362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
